AI assistant
RESMED INC — Director's Dealing 2017
Dec 18, 2017
30071_dirs_2017-12-18_dc0d3d93-3f88-4174-81aa-376085a4479c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-12-14
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-14 | ResMed Common Stock | G | 23689 | $84.43 | Disposed | 269296 | Direct |
| 2017-12-14 | ResMed Common Stock | G | 23689 | $84.43 | Disposed | 245607 | Direct |
| 2017-12-15 | ResMed Common Stock | G | 1180 | $84.97 | Disposed | 244427 | Direct |
| 2017-12-18 | ResMed Common Stock | G | 3351 | $86.00 | Disposed | 240896 | Direct |
Footnotes
F1: Represents a gift of shares to the Farrell Family Foundation. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.
F2: Represents a gift of shares to the Greater Houston Community Foundation. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.
F3: Represents a gift of shares to Project Veritas. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.
F4: The price reported above represents the average of the high and low trading price on the day of the transaction.